Structure Activity Relationships Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are the five stages of hit to lead drug discovery?

A

screening of compound libraries, hits, optimized leads, IND candidates, candidate drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What kind of binding affinity would a “hit” have?

A

1-20 um

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what kind of binding affinity would an optimized lead have?

A

0.1 -1 um

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what kind of binding affinity would an IND candidate have?

A

0.01 um

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In lead based drug design, the structure of the binding site _______ and compounds/ligands _____

A

is not known/ are known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

lead - based drug design can lead to a model of the binding site via

A

Structure activity relationship studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If you have no protein target crystal structure and no ligand or lead compound…

A

use high-throughput screeing to identify lead and crystalize protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

if you have a protein target crystal structure but no ligand or lead compound…

A

use de novo drug design - design lead compound based on binding pocket

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

if you have a ligand or lead compound but no protein target crystal structure…

A

use lead based drug design - rational design of improved compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

if you have ligand or lead compound and protein target crystal structure…

A

use structure based drug design to design new compounds based on binding site interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define pharmacophore

A

basic molecular structure of the lead compound that represents the functional groups required for activity and their spatial orientations relative to each other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

auxophore:

A

non-essential portion of a drug that supports the pharmacophore and can be modified to improve drug-like properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the 2D pharmacophore - __________ are important

A

functional groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3D pharmacophore - __________ is important

A

spatial orientation of groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do you evaluate the activity of new analogues during SAR development?

A

in vitro assays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

to determine how strucutral modifications affect biological activity against target during SAR development…

A

determine IC50 or EC50 values for each analogue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

IC50

A

half maximal inhibitory concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

EC50

A

half maximal effective concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

bioisoters for SAR:

A

atoms or functional groups that share one or more chemical/ physical characteristics and are very different in others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

characteristics to compare between bioisoters for SAR

A

size, shape, h-bonding, electronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

bioisoters are used in SAR to

A

identify the effects of size, shape, h-bonding, electronic differences at a single location of the lead compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

H and F are bioisoters because they are the same in _____ and different in ____

A

size/ h-bonding and electronically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

F and Cl are bioisoters because they are the same in ______ but different in __

A

h-bonding and electronically/ size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NH2 and CH3 are bioisoters because they are the same in ____ and different in ____

A

size/ hydrogen bonding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are some ways to optimize spatial orientation when optimizing target interactions?

A

modify 3D location of functional groups, rigidification and conformational blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

addition of functional groups can enhance __________ interactions

A

hydrophobic or ionic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

inductive effects

A

refer to electronic effects of an atom or functional group that is contributed through a single bond

28
Q

inductive effects are primarily a function of

A

electronegativity

29
Q

resonance effects

A

sharing of electrons between more than two atoms through delocalization of electrons across a pi-system

30
Q

Functional Group modifications on aromatics can alter _____ of _________

A

acidity or basicity/ other FGs on aromatic ring

31
Q

resonance effects of FG modifications on aromatics:

A

structures are stabilized through resonance structures (pi system)

32
Q

Inductive effect of -NR3+, -NH3+

A

electron withdrawing

33
Q

inductive effect of -COOH, -COOR

A

electron withdrawing

34
Q

inductive effect of -NO2

A

electron withdrawing

35
Q

inductive effect of -CN

A

electron withdrawing

36
Q

inductive effect of -CHO, -COR

A

electron withdrawing

37
Q

inductive effect of -F, -Cl, -Br, -I, -CF3

A

electron withdrawing

38
Q

inductive effect of -O-, -COO-

A

electron donating

39
Q

inductive effect of -CH3, -CR3

A

electron donating

40
Q

inductive effect of -CF3

A

electron withdrawing

41
Q

resonance effects of -COOR, -COOH

A

electron withdrawing

42
Q

resonance effects of -COR, -COH

A

electron withdrawing

43
Q

resonance effects of -SO2R

A

electron withdrawing

44
Q

resonance effects of -SO2NHR

A

electron withdrawing

45
Q

resonance effects of -NO2

A

electron withdrawing

46
Q

resonance effects of -CN

A

electron withdrawing

47
Q

resonance effects of -Ar

A

electron withdrawing

48
Q

resonance effects of -OH, -OR

A

electron donating

49
Q

resonance effects of -NH2, -NR2

A

electron donating

50
Q

resonance effects of -NHR2

A

electron donating

51
Q

resonance effects of -SH

A

electron donating

52
Q

delta G=

A

delta H - T delta S

53
Q

H=

A

enthalpy (heat)

54
Q

S=

A

entropy (disorder)

55
Q

a compound that is predisposed to its active conformation has a _____ and should demonstrate _______

A

smaller entropy change/ an increased binding affinity

56
Q

less rotation = ____ entropy

A

less

57
Q

less rotation = _______ entropic penalty

A

less

58
Q

________ prevents entropic penalty associated with adopting binding conformatiion

A

rigidification of carbon backbone

59
Q

name three aromatic amino acids

A

tyr phe trp

60
Q

goal of ring variation: maintain _____ and _________ interactions while improving _______ and _______

A

electronic/ pi stacking/ h-bonding/ pharmacokinetic

61
Q

GI50 =

A

half growth inhibition concentration

62
Q

Steps to generate IC50 values:

A

1.) test 8-10 concentrations of drug for biological activity. 2)measure biological activity and convert to a % value. Control = 100%, expreimental values are adjusted. 3) plot % of activity as a function of concentration

63
Q

how many data points do you need to have on each side of a dose response curve?

A

at least 2-3

64
Q

an IC50 change of >___ units is significant

A

10

65
Q

list three H-bonding donors:

A

OH, NH2, NHR

66
Q

list three h-bonding acceptors:

A

O, N, F